Journal of Shanghai Jiao Tong University (Medical Science) >

2022 , Vol. 42 >Issue 7: 964 - 970

DOI: https://doi.org/10.3969/j.issn.1674-8115.2022.07.018

Case report

Two cases of leukoencephalopathy with vanishing white matter caused by new mutation of EIF2B gene and literature review

  • Taotao LIU ,
  • Jingying WU ,
  • Xiaoli LIU ,
  • Mei ZHANG ,
  • Li CAO
Expand
  • 1.Department of Neurology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China
    2.Department of Neurology, The First Affiliated Hospital of Anhui University of Science and Technology, Huainan 232007, China
    3.Department of Neurology, Shanghai Fengxian District Central Hospital, Shanghai 201400, China
CAO Li, E-mail: caoli2000@yeah.net.

Received date: 2022-02-28

  Accepted date: 2022-06-08

  Online published: 2022-07-25

Supported by

National Natural Science Foundation of China(81870889)

Fold

Abstract

Two cases of leukoencephalopathy with vanishing white matter (VWM) were reported. Patient 1 was a two years and three months old girl whose main clinical manifestation was rapidly progressive motor disturbance following recurrent infections. She developed epilepsy after 6 months. After that, she was unable to walk independently and had difficulty in swallowing. Genetic testing revealed that there were compound heterozygous mutations in the EIF2B4 gene of the proband, including the c.594C>G (p.I98M) in exon 7 inherited from father and the c.1177T>A (p.Y393N) in exon 11 inherited from mother that both had not been reported previously. Cranial MRI showed diffuse symmetrical white matter lesions with prominent white matter thinning. Patient 2 was a 41-year-old female, the second adult VWM case reported in China, mainly manifesting as progressive weakness in both lower limbs and memory loss. Genetic testing revealed that there were compound heterozygous mutations in the EIF2B3 gene of the proband, including the c.130G>A (p.G44K) in exon 2 and the c.934C>G (p.R312G) in exon 8, in which the latter mutation type was reported for the first time. Cranial MRI showed white matter atrophy and ventriculomegaly. Age was a clinical predictor of the severity of VWM, and specifically earlier onset could be associated with more severe disability and higher mortality. Stress was a trigger for the disease and could contribute to neurological deterioration. At present, there is no effective therapy method for this disease. This article reports the two cases, aiming to improve clinicians' understanding of the disease and their ability of early diagnosis, so as to delay the progress of the disease and prolong the survival of the patients.

Key words： leukoencephalopathy with vanishing white matter (VWM); EIF2B gene; epilepsy; infection

Cite this article

Taotao LIU , Jingying WU , Xiaoli LIU , Mei ZHANG , Li CAO . Two cases of leukoencephalopathy with vanishing white matter caused by new mutation of EIF2B gene and literature review[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(7) : 964 -970 . DOI: 10.3969/j.issn.1674-8115.2022.07.018

References

1 HAMILTON E M C, VAN DER LEI H D W, VERMEULEN G, et al. Natural history of vanishing white matter[J]. Ann Neurol, 2018, 84(2): 274-288.
2 VAN DER KNAAP M S, KAMPHORST W, BARTH P G, et al. Phenotypic variation in leukoencephalopathy with vanishing white matter[J]. Neurology, 1998, 51(2): 540-547.
3 LEEGWATER P A, VERMEULEN G, K?NST A A, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter[J]. Nat Genet, 2001, 29(4): 383-388.
4 RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
5 VAN DER KNAAP M S, BARTH P G, GABRE?LS F J, et al. A new leukoencephalopathy with vanishing white matter[J]. Neurology, 1997, 48(4): 845-855.
6 VERMEULEN G, SEIDL R, MERCIMEK-MAHMUTOGLU S, et al. Fright is a provoking factor in vanishing white matter disease[J]. Ann Neurol, 2005, 57(4): 560-563.
7 BIANCHERI R, ROSSI A, DI ROCCO M, et al. Leukoencephalopathy with vanishing white matter: an adult onset case[J]. Neurology, 2003, 61(12): 1818-1819.
8 MATSUKAWA T, WANG X M, LIU R, et al. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5[J]. Neurogenetics, 2011, 12(3): 259-261.
9 VAN DER KNAAP M S, PRONK J C, SCHEPER G C. Vanishing white matter disease[J]. Lancet Neurol, 2006, 5(5): 413-423.
10 FOGLI A, RODRIGUEZ D, EYMARD-PIERRE E, et al. Ovarian failure related to eukaryotic initiation factor 2B mutations[J]. Am J Hum Genet, 2003, 72(6): 1544-1550.
11 WEI C B, QIN Q, CHEN F, et al. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia[J]. BMC Neurol, 2019, 19(1): 203.
12 周玲, 张海华, 陈娜, 等. 儿童白质消融性白质脑病54例的临床特点分析[J]. 中华儿科杂志, 2019, 57(11): 837-843.
12 ZHOU L, ZHANG H H, CHEN N, et al. Clinical features of 54 cases of leukoencephalopathy with vanishing white matter disease in children[J]. Chin J Pediatr, 2019, 57(11): 837-843.
13 XU L L, ZHONG M X, YANG Y Y, et al. Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis[J]. Neurol Sci, 2022, 43(4): 2659-2667.
14 JIN H, AHN J, PARK Y, et al. Identification of potential causal variants for premature ovarian failure by whole exome sequencing[J]. BMC Med Genomics, 2020, 13(1): 159.
15 SHIMADA S, SHIMOJIMA K, SANGU N, et al. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease[J]. Brain Dev, 2015, 37(10): 960-966.
16 SHIVARAM S, NAGAPPA M, SESHAGIRI D V, et al. Leukodystrophy due to EIF2B mutations in adults[J]. Can J Neurol Sci, 2021: 1-5.
17 OHLENBUSCH A, HENNEKE M, BROCKMANN K, et al. Identification of ten novel mutations in patients with eIF2B-related disorders[J]. Hum Mutat, 2005, 25(4): 411.
18 CARRA-DALLIERE C, HORZINSKI L, AYRIGNAC X, et al. Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases[J]. Rev Neurol (Paris), 2011, 167(11): 802-811.
19 SAMBATI L, AGATI R, BACCI A, et al. Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course[J]. Neurol Sci, 2013, 34(7): 1235-1238.
20 GHEZZI L, SCARPINI E, RANGO M, et al. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation[J]. Neurology, 2012, 79(20): 2077-2078.
21 LA PIANA R, VANDERVER A, VAN DER KNAAP M, et al. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation[J]. Arch Neurol, 2012, 69(6): 765-768.
22 HUMAYUN M, KHAN A. Case Report: cerebral leukodystrophy and the gonadal endocrinopathy: a rare but real association[J]. F1000Res, 2018, 7: 158.
23 LABAUGE P, HORZINSKI L, AYRIGNAC X, et al. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases[J]. Brain, 2009, 132(Pt 8): 2161-2169.
24 MATSUI M, MIZUTANI K, OHTAKE H, et al. Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter[J]. Eur Neurol, 2007, 57(1): 57-58.
25 DAMON-PERRIERE N, MENEGON P, OLIVIER A, et al. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease[J]. Clin Neurol Neurosurg, 2008, 110(10): 1068-1071.
26 LEE H N, KOH S H, LEE K Y, et al. Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations[J]. Eur J Neurol, 2009, 16(3): e42-e43.
27 VAN DER KNAAP M S, LEEGWATER P A, VAN BERKEL C G, et al. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults[J]. Neurology, 2004, 62(9): 1598-1600.
28 VILLAR-QUILES R N, DELGADO-SUáREZ C, JORQUERA-MOYA M, et al. Teaching neuroImages: adult-onset vanishing white matter disease[J]. Neurology, 2018, 90(12): e1091-e1092.
29 OHTAKE H, SHIMOHATA T, TERAJIMA K, et al. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5[J]. Neurology, 2004, 62(9): 1601-1603.
30 DENIER C, ORGIBET A, ROFFI F, et al. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis[J]. Neurology, 2007, 68(18): 1538-1539.
31 VAN DER KNAAP M S, LEEGWATER P A, K?NST A A, et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter[J]. Ann Neurol, 2002, 51(2): 264-270.
32 GOMEZ E, PAVITT G D. Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation[J]. Mol Cell Biol, 2000, 20(11): 3965-3976.
33 BUGIANI M, BOOR I, POWERS J M, et al. Leukoencephalopathy with vanishing white matter: a review[J]. J Neuropathol Exp Neurol, 2010, 69(10): 987-996.
34 VAN DER LEI H D W, VAN BERKEL C G M, VAN WIERINGEN W N, et al. Genotype-phenotype correlation in vanishing white matter disease[J]. Neurology, 2010, 75(17): 1555-1559.
35 WU Y, PAN Y X, DU L, et al. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease[J]. J Hum Genet, 2009, 54(2): 74-77.
36 DENG J, ZHOU L, ZHANG J, et al. Correlation between genotype and age of onset in leukoencephalopathy with vanishing white matter[J]. Front Genet, 2021, 12: 729777.
37 STELLINGWERFF M D, AL-SAADY M L, VAN DE BRUG T, et al. MRI natural history of the leukodystrophy vanishing white matter[J]. Radiology, 2021, 300(3): 671-680.
38 VAN DER LEI H D, STEENWEG M E, BUGIANI M, et al. Restricted diffusion in vanishing white matter[J]. Arch Neurol, 2012, 69(6): 723-727.
39 DIETRICH J, LACAGNINA M, GASS D, et al. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy[J]. Nat Med, 2005, 11(3): 277-283.
40 DOOVES S, BUGIANI M, POSTMA N L, et al. Astrocytes are central in the pathomechanisms of vanishing white matter[J]. J Clin Invest, 2016, 126(4): 1512-1524.
Options
Outlines

/

〈 〉